Table 1.
Clinical and demographic characteristics of the cohort
| Median (IQR) or % | n | |
| Age (years) | 44.3 (31.2–56.0) | 2216 |
| Female | 49.0 | 1086 |
| Male | 51.0 | 1130 |
| Age at diagnosis (years) | 19.4 (10.6–30.7) | 2199 |
| Duration of diabetes (years) | 19.4 (11.5–31.5) | 2199 |
| HbA1c 2016 (mmol/mol) | 62 (55–72) | 1941 |
| HbA1c 2016 (%) | 7.8 (7.2–8.7) | |
| SIMD rank (out of 6976) | 4449 (2594–6183) | 2151 |
| SIMD quintile 1 | 8.5 | 188 |
| SIMD quintile 2 | 18.8 | 416 |
| SIMD quintile 3 | 17.5 | 388 |
| SIMD quintile 4 | 18.0 | 399 |
| SIMD quintile 5 | 34.3 | 760 |
| SIMD data not available | 2.9 | 65 |
| Start 1 (February and March 2018) | 37.7 | 835 |
| Start 2 (April 2018) | 19.0 | 421 |
| Start 3 (May–June 2018) | 14.3 | 316 |
| Start 4 (July–September 2018) | 12.8 | 284 |
| Start 5 (October 2018–February 2019) | 16.2 | 360 |
| Completed DAFNE | 32.5 | 721 |
| CSII user | 21.3 | 472 |
CSII, continuous subcutaneous insulin infusion; DAFNE, Dose Adjustment for Normal Eating; HbA1c, hemoglobin A1c; SIMD, Scottish Index of Multiple Deprivation.